| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |